Development of Fibro-PeN, a clinical prediction model for mo... : Hepatology Development of
Fibro-PeN, a clinical prediction model for moderate-to-severe fibrosis in children with …

Prediction models are everywhere in clinical medicine. We use them to assign a diagnosis
or a prognosis, and there is a continuous effort to develop better prediction models. It is …

Abstract Background and Aims Non-alcoholic fatty liver disease (NAFLD) is a progressive
liver disease that ranges from simple steatosis to inflammation, fibrosis, and cirrhosis. To …

During the last 10 to 15 years, the progressive introduction of noninvasive tests (NITs) for the
diagnosis and management of chronic liver diseases (CLDs) has had a major impact in …

Background: There are no published studies on the prevalence of non-alcoholic fatty liver
disease (NAFLD) in patients with atopic dermatitis (AD). Objectives: To estimate the …

Résumé Le foie stéatosique non alcoolique représente l'une des pathologies hépatiques les
plus fréquentes, affectant 25 à 30% de la population mondiale. Alors que sa forme …

Objectives To systematically review the accuracy of spleen stiffness measurement (SSM) by
2D-Shear Wave Elastography (2D-SWE) in predicting high risk for bleeding varices (HRV) in …

Abstract Background and Aim Magnetic resonance elastography (MRE) is used for the
evaluation of liver fibrosis; however, it remains unclear whether MRE‐based liver stiffness is …

The medical term nonalcoholic fatty liver disease (NAFLD) was coined in 1986 for a
condition that has since become the most prevalent liver disorder worldwide. In the last 3 …

Die Prävalenz der Fettlebererkrankung hat in den letzten Jahren auch in Deutschland
erheblich zugenommen. Sie gehört mit geschätzten 18 Mio. betroffenen Bundesbürgern …